Clinical Trial Update: [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer [Phase 2]

View source ↗

Summary

The clinical trial update reports the completion of a Phase 2 study evaluating [68Ga]Ga-FAPI PET/CT imaging in gastric cancer and gastroesophageal junction canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• [68Ga]Ga-FAPI PET/CT (Ga-68 labeled fibroblast activation protein inhibitor (FAPI) imaging tracer)

Snippet

Sponsor: Aalborg University Hospital | Conditions: Gastric Cancer, Gastro Esophageal Junctional Cancer | Phase 2 | Status: COMPLETED